What is the role of risk assessment tools in deciding screening intervals and modalities?

• A. Risk models (e.g., Gail, Tyrer-Cuzick) estimate lifetime and five-year risk to tailor screening strategies; high-risk individuals may start earlier or use MRI screening in addition to mammography.
• B. Risk models replace imaging entirely.
• C. They have no role in screening.
• D. They only assess genetic risk.

Answer: (A)

Risk assessment tools guide screening decisions by assigning an individual’s likelihood of developing breast cancer, so screening can be tailored rather than using a one-size-fits-all approach. Models like Gail and Tyrer-Cuzick combine factors such as age, family history, reproductive history, breast density, and sometimes genetic information to estimate both lifetime risk and short-term (e.g., five-year) risk. With that risk estimate, clinicians may start screening earlier or more frequently for those at higher risk, and may add MRI in addition to mammography because MRI offers greater sensitivity in detecting cancers in dense breasts or in high-risk individuals. Conversely, those at average or lower risk typically follow standard screening intervals and modalities. Importantly, these tools complement imaging rather than replace it, and they assess more than just genetic risk.